Similarly, while we observed increased frequencies of Trp2-specific tumor-infiltrating CD8+ T-cells in mice receiving Trp2Vax, TA99-HL2-KOA1 treatment did not further increase frequency of this population (Figure 3D). This evidence concerns the gene CD8A and neoplasm.